Barrett's esophagus treatment showdown: which procedure hurts less?
NCT ID NCT05051475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two endoscopic treatments for Barrett's esophagus, a condition that can lead to esophageal cancer. The goal was to see which procedure—radiofrequency ablation or hybrid argon plasma coagulation—causes less pain and is safer from the patient's viewpoint. Sixty-two adults with Barrett's esophagus took part, and researchers measured pain right after the procedure, at 7 days, and at 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- endoscopic radiofrequency ablation or hybrid argon plasma coagulation
- What this could lead to
- If one method proves more acceptable and safer, it could become the preferred treatment for Barrett's esophagus, reducing discomfort for patients.
- What could go wrong
- This is a small, completed study (62 people) comparing two established techniques, so it won't introduce a new treatment. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Centre for Postgraduate Education
Warsaw, 02-781, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized radiation pulses could boost esophageal cancer treatment
- Could a dye and camera spare esophageal cancer patients from extensive lymph node removal?
- Which biopsy method best spots early esophageal cancer?
- New cutting tool may outperform heat therapy for Barrett's esophagus
- Can a simple blood test predict leukemia risk after cancer therapy?
- Real-World study tracks Nivolumab's impact on advanced stomach and esophageal cancers